Table: Ono Pharm -2025/26 group results (IFRS)

ONO PHARMACEUTICAL

08/05/2026 04:00

May 8 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Mar 31, 2026    Mar 31, 2025   Mar 31, 2027      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            515.79          486.87         455.00                 
                 (+5.9 pct)      (-3.1 pct)     (-11.8 pct)              
  Operating         92.24           59.75          94.00                 
                 (+54.4 pct)     (-62.6 pct)    (+1.9 pct)               
  Pretax            92.65           59.33          94.00                 
                 (+56.2 pct)     (-63.8 pct)    (+1.5 pct)               
  Net               69.77           50.05          71.00                 
                 (+39.4 pct)     (-60.9 pct)    (+1.8 pct)               
  EPS Basic      148.49 yen      106.55 yen     151.09 yen               
  EPS Diluted    148.41 yen      106.41 yen                              
  Ann Div         80.00 yen       80.00 yen      80.00 yen               
  -Q2 Div         40.00 yen       40.00 yen      40.00 yen               
  -Q4 Div         40.00 yen       40.00 yen      40.00 yen               
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T